Yıl: 2011 Cilt: 26 Sayı: 3 Sayfa Aralığı: 269 - 270 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab

Öz:
-
Anahtar Kelime:

Konular: Romatoloji

TNF-alfa Bloke Edici Ajan Adalimumabla Yürütülen Aktif Ankilozan Spondilit Tedavisi Sırasında Meydana Gelen Yeni Başlangıçlı Palmoplantar Psoriyazis

Öz:
-
Anahtar Kelime:

Konular: Romatoloji
Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
  • Takahashi H, Hashimoto Y, Ishida-Yamamoto A, Ashida T, Kohgo Y, Iizuka H . Psoriasiform and pustular eruption induced by infliximab . J Dermatol 2007;34:468-72 .
  • Lee HH, Song IH, Friedrich M, Gauliard A, Detert J, Röwert J, et al . Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists . Br J Dermatol 2007;156:486-91 .
  • Kerbleski JF, Gottlieb AB . Dermatological complications and safety of anti-TNF treatments . Gut 2009;58:1033-9 .
  • Exarchou SA, Voulgari PV, Markatseli TE, Zioga A, Drosos AA . Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors . Scand J Rheumatol 2009;38:328-31 .
  • Borrás-Blasco J, Gracia-Perez A, Nuñez-Cornejo C, Rosique-Robles JD, Mateu-Puchades A, Casterá MD, et al . Exacerbation of psoriatic skin lesions in a patient with psoriatic arthritis receiving adalimumab . J Clin Pharm Ther 2008;33:321-5 .
  • Collamer AN, Guerrero KT, Henning JS, Battafarano DF . Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action . Arthritis Rheum 2008;59:996-1001 .
  • Ko JM, Gottlieb AB, Kerbleski JF . Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases . J Dermatolog Treat 2009;20:100-8 .
  • Fiorino G, Allez M, Malesci A, Danese S . Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease . Aliment Pharmacol Ther 2009;29:921-7 .
  • de Gannes GC, Ghoreishi M, Pope J, Russell A, Bell D, Adams S, et al . Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions . Arch Dermatol 2007;143:223-31 .
  • Aeberli D, Seitz M, Jüni P, Villiger PM . Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors . Rheumatology (Oxford) 2005;44:172-5 .
APA Akgul O, Calis M, ÖZGÖÇMEN S (2011). New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab. , 269 - 270.
Chicago Akgul Ozgur,Calis Mustafa,ÖZGÖÇMEN Salih New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab. (2011): 269 - 270.
MLA Akgul Ozgur,Calis Mustafa,ÖZGÖÇMEN Salih New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab. , 2011, ss.269 - 270.
AMA Akgul O,Calis M,ÖZGÖÇMEN S New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab. . 2011; 269 - 270.
Vancouver Akgul O,Calis M,ÖZGÖÇMEN S New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab. . 2011; 269 - 270.
IEEE Akgul O,Calis M,ÖZGÖÇMEN S "New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab." , ss.269 - 270, 2011.
ISNAD Akgul, Ozgur vd. "New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab". (2011), 269-270.
APA Akgul O, Calis M, ÖZGÖÇMEN S (2011). New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab. Turkish Journal of Rheumatology(.)Archives of Rheumatology, 26(3), 269 - 270.
Chicago Akgul Ozgur,Calis Mustafa,ÖZGÖÇMEN Salih New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab. Turkish Journal of Rheumatology(.)Archives of Rheumatology 26, no.3 (2011): 269 - 270.
MLA Akgul Ozgur,Calis Mustafa,ÖZGÖÇMEN Salih New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab. Turkish Journal of Rheumatology(.)Archives of Rheumatology, vol.26, no.3, 2011, ss.269 - 270.
AMA Akgul O,Calis M,ÖZGÖÇMEN S New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab. Turkish Journal of Rheumatology(.)Archives of Rheumatology. 2011; 26(3): 269 - 270.
Vancouver Akgul O,Calis M,ÖZGÖÇMEN S New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab. Turkish Journal of Rheumatology(.)Archives of Rheumatology. 2011; 26(3): 269 - 270.
IEEE Akgul O,Calis M,ÖZGÖÇMEN S "New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab." Turkish Journal of Rheumatology(.)Archives of Rheumatology, 26, ss.269 - 270, 2011.
ISNAD Akgul, Ozgur vd. "New-Onset Palmoplantar Psoriasis During Treatment of Active Ankylosing Spondylitis with TNF-alpha Blocking Agent Adalimumab". Turkish Journal of Rheumatology(.)Archives of Rheumatology 26/3 (2011), 269-270.